Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Lakewood-Amedex Biotherapeutics

LABT

----

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Weekly Recap | LABT.US -10.36%, Nu-3 set for Phase 2a trial
Weekly Review·Sep 19 at 06:14 AM
LABT-3.49%
Weekly Recap | LABT.US +18.09%, consensus target above spot
Weekly Review·Sep 12 at 06:12 AM
LABT-3.49%
Weekly Recap | LABT.US -18.26%, a volatile fade from highs
Weekly Review·Sep 5 at 07:21 AM
LABT-3.49%
Lakewood-Amedex (LABT.US) Surges 25% Intraday
Movers Alert·May 1 at 03:01 PM
LABT-3.49%
Lakewood-Amedex Soars Over 53% Amid Board Appointment
Movers Alert·May 1 at 01:39 PM
LABT-3.49%
Lakewood-Amedex Biotherapeutics Drops Over 3% Intraday
Movers Alert·Apr 24 at 03:29 PM
LABT-3.49%